Antibiotic Use Among Children Requiring Respiratory Support in Intensive Care Unit (ICU) from Sofia, Bulgaria: A

Lilia Bozadzhieva1,2, Dimitrinka Miteva2,3, Lyubomila Ilarionova1,2

  • 1Pediatric Intensive Care Unit, University Hospital for Active Treatment of Children's Diseases "Professor Ivan Mitev", Akademik Ivan Evstatiev Geshov Blvd 11, 1431 Sofia, Bulgaria.

PubMed

Insights

Antibiotic use is common in critically ill children needing respiratory support, driven by illness severity, not just ventilation type. Invasive ventilation increased specific infections like ventilator-associated pneumonia.

Area of Science:

  • Pediatric Critical Care Medicine
  • Infectious Diseases
  • Respiratory Medicine

Background:

  • Antibiotic use in pediatric intensive care units (PICU) for respiratory support lacks standardized guidelines, especially for non-invasive ventilation (NIV).
  • Limited evidence necessitates real-world data on antibiotic prescribing and infectious outcomes in critically ill children.
  • Understanding these patterns is crucial for developing effective antibiotic stewardship.

Purpose of the Study:

  • To describe antibiotic prescribing patterns in pediatric patients with respiratory failure.
  • To analyze infectious outcomes based on the type of respiratory support received (oxygen, NIV, invasive mechanical ventilation - IMV).
  • To identify factors influencing antibiotic use and infection rates in this population.

Main Methods:

  • Retrospective single-center study of children (0-17 years) admitted to the PICU between January 2021 and February 2025.
  • Inclusion criteria: requirement for oxygen supplementation, NIV, or IMV.
  • Data collected: demographics, underlying conditions, infectious complications, antibiotic exposure, PICU stay, and outcomes. Analyzed using descriptive statistics and univariate comparisons.

Main Results:

  • Eighty-nine patients were included in the analysis.
  • Ventilator-associated pneumonia (VAP) occurred exclusively in IMV patients; overall infection complications were higher with IMV versus NIV (p=0.005).
  • Antibiotics were given to 82% of patients; use was similar across ventilation types (p=0.195), but IMV patients received more antibiotics. *Pseudomonas aeruginosa* was the most common pathogen.

Conclusions:

  • Antibiotic use in PICU patients with respiratory support is frequent, influenced more by disease severity than ventilation method.
  • Infections like VAP are more common with IMV; caution is needed when interpreting non-invasive group outcomes due to varying definitions.
  • Findings are descriptive, emphasizing the need for prospective multicenter studies to guide evidence-based antibiotic stewardship in pediatric critical care.

Related Concept Videos

Respiratory Assessment: Purpose and Indications01:19

Respiratory Assessment: Purpose and Indications

Respiratory assessment is a cornerstone of nursing assessments, crucial for the early detection of patient deterioration. This evaluation transcends routine procedures, representing a critical skill nurses must master to ensure optimal patient care.
Objectives and Importance:
The primary goal of respiratory assessment is to evaluate patients at early risk of clinical deterioration. Since respiratory distress often precedes other signs of declining health, breathing patterns and sounds become a...
2.1K
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
1.6K
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
1.2K
Sputum Studies II: Culture and Sensitivity01:20

Sputum Studies II: Culture and Sensitivity

Description
Sputum culture and sensitivity is a medical procedure used to diagnose bacterial infections in the respiratory tract and select the most appropriate antibiotics for treatment. This process involves analyzing sputum samples of thick and opaque secretions produced in the lungs and airways. These samples are collected from patients and then sent to the laboratory for analysis.
The test can identify various pathogens responsible for respiratory infections, including Streptococcus,...
2.0K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
408
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
90